Why Celgene Stock Is Still A Good Investment Opportunity
- Celgene will continue to benefit from the increasing demand for its key growth driver Revlimid.
- Celgene has good valuation metrics and strong earnings growth prospects; its PEG ratio is very low at 0.94.
- Celgene raised its 2014 outlook.
- Celgene has top-quality pipeline which should sustain long-term growth.